Azithromycin ophthalmic - InSite Vision
At a glance
- Drug Originator InSite Vision
- Drug Licenced by Akorn; Biem Ilac; Bioceutica; Essex Bio-Technology; Knight Therapeutics; Merck & Co; Nitten Pharmaceutical; Senju Pharmaceutical; Shin Poong Pharmaceutical; Unknown
- Drug Class Anti-inflammatories; Antibacterials; Antivirals; Eye disorder therapies; Macrolides; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
- USA Patent Applicants THEA PHARMA
- USA Patents 6
- NDAs 1
Table of Contents
Disclaimer